Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesThe Cooper Companies, Inc

The Cooper Companies, Inc

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
62.51 USD -0.42 ( 0.67%)
Last update at 2026-11-12T15:16:00Z
VOLUME
224671
Market Cap
10129.57M
P/E
18.63

Momentum Score

…

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
62.51
Low
63.50
High
52 Week Price Range
51.01
Low
89.83
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

The Cooper Companies operates globally through CooperVision (contact lenses) and CooperSurgical (women's health and fertility devices), supplying lenses, surgical equipment and related services. Longer-term growth may be supported by rising contact-lens penetration and demand for premium and myopia-management lenses, expanding fertility and reproductive-health services, and selective M&A that could broaden product reach; investors may find the company attractive for its diversified med‑tech exposure and recurring revenue streams.
Key risks include intense competition in vision care, regulatory and reimbursement pressures, execution and integration risk from acquisitions, and sensitivity to elective-procedure volumes and foreign-exchange movements.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
62.93
Dividend Yield
-
Revenue TTM
4236.90M
Revenue Per Share
21.69
Gross Profit TTM
2793.30M
Debt / Equity
0.34
ROE
6.84%
Net Debt
2673.00M
ROCE
5.59%
Diluted EPS TTM
2.86

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Income before tax 566.50M 582.30M 412.90M 475.30M 491.50M
Net income 374.90M 392.30M 294.20M 385.80M 2944.70M
Selling general administrative 1627.80M 1533.70M 1501.20M 1342.20M 1211.20M
Gross profit 2482.90M 2595.70M 2357.90M 2139.60M 1955.80M
Reconciled depreciation 377.40M 375.10M 186.20M 179.50M 146.10M
Ebit 630.40M 696.60M 518.20M 507.60M 505.80M
Ebitda 1053.40M 1071.70M 704.40M 712.10M 660.70M
Depreciation and amortization 423.00M 375.10M 186.20M 204.50M 154.90M
Non operating income net other - - - 25.00M 8.80M
Operating income 682.90M 705.70M 533.10M 507.60M 505.80M
Other operating expenses 3409.50M 3189.70M 3060.10M 2800.80M 2416.70M
Interest expense 100.00M 114.30M 105.30M 57.30M 23.10M
Tax provision 191.60M 190.00M 118.70M 89.50M -2453.20M
Interest income - - - 57.30M 23.10M
Net interest income -100.00M -114.30M -105.30M -57.30M -23.10M
Income tax expense 191.60M 190.00M 118.70M 89.50M -2453.20M
Total revenue 4092.40M 3895.40M 3593.20M 3308.40M 2922.50M
Total operating expenses 1800.00M 1890.00M 1824.80M 1632.00M 1450.00M
Cost of revenue 1609.50M 1299.70M 1235.30M 1168.80M 966.70M
Total other income expense net -116.40M -123.40M -14.90M -32.30M -14.30M
Net income from continuing ops 374.90M 392.30M 294.20M 385.80M 2944.70M
Net income applicable to common shares - - - 385.80M 2944.70M
Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Total assets 12394.80M 12315.20M 11658.90M 11492.30M 9606.20M
Intangible assets 1586.30M 1791.00M 1710.30M 1885.10M 1271.50M
Other current assets 320.80M 324.20M 238.80M 208.90M 179.30M
Total liab 4155.70M 4231.60M 4107.90M 4317.60M 2664.20M
Total stockholder equity 8238.90M 8083.40M 7551.00M 7174.70M 6942.00M
Deferred long term liab - - - 149.90M 24.10M
Other current liab 598.20M 599.10M 538.10M 525.20M 649.20M
Common stock 21.80M 21.70M 5.40M 5.40M 5.40M
Capital stock 21.80M 21.70M - 5.40M 5.40M
Retained earnings 7643.30M 7268.40M 6876.10M 6584.90M 6202.10M
Other liab - - - 686.60M 304.30M
Good will 3853.40M 3838.40M 3624.50M 3609.70M 2574.00M
Other assets - - - 3031.00M 2690.80M
Cash 110.60M 107.60M 120.80M 138.20M 95.90M
Cash and equivalents - - - 138.20M 95.90M
Total current liabilities 1112.80M 1022.80M 969.00M 1280.20M 732.10M
Current deferred revenue 127.90M 129.90M 123.60M 93.60M -161.40M
Net debt 2673.00M 2476.10M 2448.40M 2625.20M 1614.80M
Short term debt 86.30M 33.30M 45.40M 412.60M 82.90M
Short long term debt 47.10M 32.20M 45.40M 412.60M 82.90M
Short long term debt total 2783.60M 2583.70M 2569.20M 2763.40M 1710.70M
Other stockholder equity 980.30M 1215.00M 1123.10M 1051.20M 1075.80M
Property plant equipment - - - 1432.90M 1604.60M
Total current assets 2106.40M 1951.50M 1704.90M 1533.60M 1465.30M
Net tangible assets - - - 1679.90M 3096.50M
Net receivables 829.00M 717.00M 609.70M 557.80M 515.30M
Long term debt 2455.70M 2548.00M 2523.80M 2350.80M 1396.10M
Inventory 846.00M 802.70M 735.60M 628.70M 585.60M
Accounts payable 300.40M 260.50M 261.90M 248.80M 161.40M
Noncontrolling interest in consolidated entity - - - 0.20M 0.20M
Accumulated other comprehensive income -406.50M -421.70M -453.80M -466.80M -341.30M
Common stock total equity - - - 5.40M 5.40M
Retained earnings total equity - - - 6584.90M 6202.10M
Treasury stock - - - - -639.60M
Non currrent assets other 689.20M 660.60M 637.10M 587.90M 144.20M
Non current assets total 10288.40M 10363.70M 9954.00M 9958.70M 8140.90M
Capital lease obligations 2.50M 3.50M - 20.60M 231.70M
Long term debt total - - - 2350.80M 1396.10M
Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Investments - -764.60M -449.00M 52.10M -450.30M
Change to liabilities - - 5.50M 20.70M 31.40M
Total cashflows from investing activities -372.90M -764.60M -449.00M -1831.20M -450.30M
Net borrowings -79.90M 5.60M -180.80M 1278.80M -309.90M
Total cash from financing activities -425.90M 39.20M -173.90M 1193.70M -311.40M
Change to operating activities - - -58.20M -70.00M -59.20M
Net income 374.90M 392.30M 294.20M 385.80M 2944.70M
Change in cash 2.90M -13.20M -17.70M 42.00M -20.20M
Begin period cash flow 107.70M 120.90M 138.60M 96.60M 116.80M
End period cash flow 110.60M 107.70M 120.90M 138.60M 96.60M
Total cash from operating activities 796.10M 709.30M 607.50M 692.40M 738.60M
Depreciation 423.00M 413.80M 367.70M 346.10M 309.30M
Other cashflows from investing activities - - - -1641.30M -235.90M
Dividends paid 0.00M 0.00M 3.00M 3.00M 3.00M
Change to inventory -46.00M -59.30M -105.40M -40.40M -9.20M
Change to account receivables -120.30M -117.10M -60.20M -33.80M -75.50M
Sale purchase of stock -290.10M 8.30M -23.00M -78.50M -24.80M
Other cashflows from financing activities -71.90M -30.30M 1783.00M 1836.70M -0.10M
Change to netincome - - 164.40M 100.10M -2397.90M
Capital expenditures 362.40M 421.20M 392.50M 242.00M 214.40M
Change receivables - - - -33.80M -75.50M
Cash flows other operating - - - -86.10M -64.20M
Cash and cash equivalents changes - - - 54.90M -23.10M
Change in working capital -284.80M -333.70M -218.80M -174.00M -149.90M
Stock based compensation 70.50M 75.10M 62.10M 54.20M 43.80M
Other non cash items 147.80M 118.00M 57.60M 26.40M 92.90M
Free cash flow 433.70M 288.10M 215.00M 450.40M 524.20M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
COO
The Cooper Companies, Inc		 -0.42
0.67%		 62.51 18.63 11.10 2.39 1.24 3.00 13.57
ISRG
Intuitive Surgical Inc		 -8.88
1.97%		 440.65 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -2.56
1.26%		 200.18 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -1.98
1.94%		 99.87 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 0.83
0.39%		 215.35 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

The Cooper Companies, Inc

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583

925 460 3600

https://www.coopercos.com

15000

Name Title Year Born
Mr. Albert G. White III Pres, CEO & Non-Independent Director 1970
Mr. Brian G. Andrews Exec. VP, CFO & Treasurer 1979
Mr. Daniel G. McBride Esq. Exec. VP & COO 1964
Mr. Agostino Ricupati Sr. VP & Chief Accounting Officer 1967
Ms. Holly R. Sheffield Pres of CooperSurgical, Inc. 1971
Mr. Kim Duncan VP of Investor Relations & Risk Management NA
Mr. Nicholas S. Khadder Gen. Counsel & Corp. Sec. 1974
Mr. Juan Carlos Aragon Pres of CooperVision Specialty EyeCare Division NA
Mr. Gerard H. Warner III Pres of CooperVision, Inc. 1965
Mr. Albert G. White III President, CEO & Non-Independent Director 1970

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…